▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Sean Williams

TMFUltraLong

@AMCScam

Sean Williams is a data-driven Motley Fool contributing analyst who's been investing for 26 years and has penned north of 15,000 articles. You'll find him at the intersection of politics and investing tackling macroeconomic topics of interest (Social Security and Donald Trump's economic/tax policies), analyzing which stocks billionaire investors (e.g., Warren Buffett) are buying and selling, and digging into how the world's most-influential businesses and trends -- everything from the evolution of artificial intelligence (AI) to the next stock split -- are changing Wall Street. He holds a B.A. in Economics from the University of California, San Diego.

Recent Articles by Sean Williams

Apr 18, 2015 by Sean Williams

3 Worrisome Obamacare Trends That Could Put Its Long-Term Success in Jeopardy

Certain aspects of Obamacare have been an early success, but these three trends suggest that it could still just as easily fail to deliver on its promise of improving the healthcare landscape for consumers.

Feb 15, 2017 by Sean Williams

15 Wise Moves to Make With Your Enormous Tax Refund

According to the latest figures from the IRS, the average tax refund in 2014 totaled nearly $2,900. Here are 15 novel ways you can wisely put that money to work if you were on the receiving end of money from the U.S. government.

Apr 18, 2015 by Sean Williams

Would You Have Guessed This Is the Apparel Retailer Consumers Are Most Loyal to?

U.S. apparel sales have more than doubled since 1992, but so have the number of retail choices for consumers. Find out which surprising apparel retailer is the best at creating loyal customers, according to this latest study.

Apr 18, 2015 by Sean Williams

Meet the Game-Changing Drug Designed to Fight America's Leading Cause of Death

This disease claimed more than 600,000 lives in the U.S. in 2013, according to the CDC, but an experimental drug with a possible approval date in 2015 could put a dent in these mortality figures going forward.

Apr 15, 2015 by Sean Williams

Johnson & Johnson Earnings: 5 Initial Takeaways

Johnson & Johnson's headline figures don't tell the full story behind its first-quarter earnings report. Dig a bit deeper to uncover these five key takeaways.

Apr 15, 2015 by Sean Williams

Is InvenSense Inc. Worthy of This Upgrade and 33% Price Target Hike?

Well off its 52-week high, MEMS-maker InvenSense catches a substantial upgrade and price target hike from one Wall Street firm. Find out whether this positive shift is deserved or wishful thinking.

Apr 15, 2015 by Sean Williams

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks may have been clobbered in recent months, but they all may be poised for substantial rebounds.

Apr 14, 2015 by Sean Williams

3 Cheap Dividend Stocks You Can Buy Right Now

If you're on the lookout for cheap dividend stocks, you certainly couldn't go wrong by starting your research with these three companies.

Apr 12, 2015 by Sean Williams, Selena Maranjian, and Dan Caplinger

3 Healthcare Stocks You Can Buy and Hold Forever

The healthcare sector is constantly changing, but three of our top analysts would suggest that you can safely buy and hold these three healthcare stocks forever!

Apr 12, 2015 by Sean Williams

This New Study Is Bad News if You're a Marijuana Supporter

The American public is swaying more and more in favor of legalizing marijuana. But one factor that could curb marijuana's momentum was on full display in this latest study.

Apr 12, 2015 by Sean Williams

In Case You Missed It, This Study May Have Uncovered a New Way to Fight Cancer

Years from now this new study may change the way pharmaceutical companies and physicians fight cancer.

Apr 12, 2015 by Sean Williams

Here's Why You Might Be Kissing Your Social Security Check Goodbye

Many people are counting on their Social Security income to fuel their retirement, but according to this latest study one astronomical expense has the potential to consume a vast majority of your lifetime Social Security benefits.

Apr 11, 2015 by Sean Williams

3 Common but Complex Social Security Questions Answered

If you've got complex questions about Social Security, we've got answers!

Apr 11, 2015 by Sean Williams, Tyler Crowe, and Matt DiLallo

3 High-Yield Energy Dividends Wall Street is Missing

High-profile dividend stocks are everywhere, but sometimes the best high-yield dividend stocks fly under the radar.

Apr 11, 2015 by Sean Williams, Todd Campbell, and George Budwell

The Big Pharma Stock We'd Buy and Hold for the Next 20 Years

Despite the threat of patent losses, our analysts believe these Big Pharma stocks would be smart investments over the next 20 years.

Apr 11, 2015 by Sean Williams

When It Comes to Brand Loyalty, This Automaker Is Driving Over Its Competition

U.S. auto sales hit their highest levels since 2006 last year, but not all car brands are created equal. Find out which auto brands are the best at engaging consumers and changing them from car buyers into customers for life.

Apr 11, 2015 by Sean Williams

A Possible Glimpse Into the Future: Is a $1 Prostate Cancer Test on the Way?

A more accurate and significantly cheaper prostate cancer screening test? Find out what researchers at the University of Central Florida are up to -- and how it could transform prostate cancer diagnoses many years down the road.

Apr 11, 2015 by Sean Williams

The Battle for Your Banking Business Is Taking an Interesting Turn

In a recent survey, 11% of respondents admitted to changing their primary checking account to a new bank over the trailing year. But the reasoning behind the move, and who's making these moves, is where the buzz really is!

Apr 10, 2015 by Sean Williams

Zogenix Inc. Shares Crumbled in March -- Here's Why

Zogenix shares stumbled 18% in March after the company reported a double dose of unwelcome news on the same day. See what riled up shareholders, and whether Zogenix's pullback is an opportunity to buy.

Apr 10, 2015 by Sean Williams

7 High-Dividend Stocks in Healthcare

Quality high-dividend stocks in the healthcare sector aren't as easy to find as you might think. But, if you're choosy, you could land a winner.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services